IPOPI joins the Critical Medicines Alliance

IPOPI has recently joined the Critical Medicines Alliance, an initiative launched by the European Commission for the next 5 years. The objective of the Alliance is “to serve as a consultative body to identify priorities for action and propose solutions to strengthen the supply of critical medicines in the European Union, to prevent better and combat their shortages”. IPOPI will represent the voice of patients with primary immunodeficiencies and their need for a stable supply of therapies.

Stay tuned for further news!